Your browser doesn't support javascript.
loading
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone.
Park, Jungsin; Kim, Choon Ok; Oh, Eun Sil; Lee, Jung Il; Kim, Ja Kyung; Ahn, Sang Hoon; Kim, Do Young; Kim, Seung Up; Kim, Beom Kyung; Chung, Yong Eun; Kim, Se-Mi; Park, Min Soo.
Affiliation
  • Park J; Department of Pharmaceutical Medicine and Regulatory Science, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, Republic of Korea.
  • Kim CO; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Oh ES; Department of Pharmaceutical Medicine and Regulatory Science, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, Republic of Korea.
  • Lee JI; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim JK; Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Gyeonggi-do, Republic of Korea.
  • Ahn SH; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim DY; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim SU; Yonsei Liver Centre, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim BK; Yonsei Liver Centre, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Chung YE; Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim SM; Department of Nonclinical Development, Chong Kun Dang Research Institute, Chong Kun Dang Pharmaceutical Corp., Ltd, Seoul, Republic of Korea.
  • Park MS; Department of Pharmaceutical Medicine and Regulatory Science, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, Republic of Korea.
Clin Pharmacol Drug Dev ; 11(5): 576-584, 2022 05.
Article in En | MEDLINE | ID: mdl-35255191
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thiazolidinediones / Liver Diseases Limits: Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thiazolidinediones / Liver Diseases Limits: Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Type: Article